Patton Albertson Miller Group LLC Sells 2,899 Shares of Stryker Corporation $SYK

Patton Albertson Miller Group LLC reduced its stake in shares of Stryker Corporation (NYSE:SYK) by 15.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 15,765 shares of the medical technology company’s stock after selling 2,899 shares during the period. Patton Albertson Miller Group LLC’s holdings in Stryker were worth $5,541,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of SYK. United Financial Planning Group LLC bought a new position in Stryker in the 3rd quarter worth approximately $27,000. Strive Asset Management LLC bought a new position in Stryker in the 3rd quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd bought a new position in Stryker in the 3rd quarter worth approximately $34,000. Copia Wealth Management boosted its holdings in Stryker by 181.6% in the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after buying an additional 69 shares during the period. Finally, Ares Financial Consulting LLC bought a new position in Stryker in the 4th quarter worth approximately $40,000. 77.09% of the stock is owned by institutional investors.

Stryker Stock Performance

NYSE SYK opened at $292.13 on Thursday. Stryker Corporation has a 1 year low of $289.91 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock has a market capitalization of $111.88 billion, a PE ratio of 33.81, a P/E/G ratio of 1.86 and a beta of 0.80. The company’s 50 day simple moving average is $342.12 and its two-hundred day simple moving average is $355.73.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. During the same quarter in the prior year, the company earned $2.84 earnings per share. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts predict that Stryker Corporation will post 14.97 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Leerink Partners assumed coverage on shares of Stryker in a report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price objective for the company. Canaccord Genuity Group cut their price objective on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. UBS Group cut their price objective on shares of Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Evercore set a $355.00 target price on shares of Stryker in a research note on Friday, May 1st. Finally, The Goldman Sachs Group reiterated a “neutral” rating and issued a $361.00 target price on shares of Stryker in a research note on Friday, May 1st. Sixteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.